ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/FLT3-inhibitor

Search results

target/FLT3-inhibitor
9 trial(s) found.
NCT06824168
NA
NA
NCT06578247
NCT06366789
NCT04581512
NCT04293562
NCT03409081
ACTRN12624000082505
ACTRN12621000991819
Not Applicable
ACTRN12616001187437
Filters
FLT3
100%
KIT
44%
AXL
44%
Bcl2
22%
ALK
22%
BCR-ABL1
22%
CDK4
22%
CDK6
22%
CRAF
22%
EGFR
22%
MET
22%
PDGFR
22%
PDGFRA
22%
RAF
22%
ROS1
22%
SRC
22%
VEGFR
22%
YES1
22%
mTOR
22%
mTORC1
22%
AURKA
11%
AURKB
11%
Aurora
11%
DNA methyltransferase
11%
CD33
11%
ATR
11%
JAK1
11%
JAK2
11%
PI3K
11%
SMO
11%
mTORC2
11%
ERBB2
11%
FGFR1
11%
FGFR1/2/3
11%
FGFR2
11%
FGFR3
11%
FGFR4
11%
HDAC
11%
IGF1R
11%
MEK
11%
PARP
11%
RET
11%
VEGFR2
11%
proteasome
11%
NA 




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.